Exploring biomarkers for prediabetes and diabetes using MALDI-TOF MS technology
Official title: Research on Potential Biomarkers of Prediabetes and Diabetes Based on MALDI-TOF MS Platform.
Run by Zhujiang Hospital · NCT06097065 · Data updated 2026-11-12
This study is trying to find new markers in blood and urine samples that can help doctors better diagnose prediabetes and diabetes in different groups of people, including pregnant women.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 2860 (estimated) |
| Sponsor | Zhujiang Hospital Academic / other |
| Locations | 1 site (Guangzhou, Guangdong) |
| Status | Recruiting |
| Started | May 20, 2022 |
| Main results expected | December 31, 2025 |
| Study ends | December 31, 2026 |
| Registry record updated | October 24, 2023 |
| Trial ID | NCT06097065 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals with prediabetes, diabetes, or gestational diabetes, as well as healthy controls with normal glucose tolerance.
✕Probably not a fit
Patients who do not have any form of glucose metabolism disorder or those who are not pregnant may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to investigate the differences in proteomics and peptidomics between fasting serum/plasma and urine samples from individuals with normal glucose tolerance and those with prediabetes or diabetes, as well as pregnant individuals with and without gestational diabetes. By utilizing the MALDI-TOF MS platform, the study seeks to identify potential new diagnostic markers for prediabetes and diabetes. The goal is to establish a clinical predictive diagnostic model based on these differences, which could enhance the accuracy of diagnosing these conditions.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic methods for prediabetes and diabetes, allowing for earlier intervention and better management of these conditions.
How similar studies have gone: While the approach of using MALDI-TOF MS for biomarker discovery is established, the specific application to differentiate prediabetes and diabetes in this manner is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Inclusion criteria for cases: Non pregnant people: the remaining fasting serum/plasma and urine samples of prediabetes/diabetes patients (prediabetes: IFG: FPG 6.1-6.9mmol/L, Blood glucose 2h after meal\<7.8mmol/L(WHO); IGT: FPG\<7.0mmol/L, Blood glucose 2h after meal 7.8-11.1mmol/L(WHO); diabetes: Typical symptoms of diabetes, FPG \>= 7.0mmol/L or 75g OGTT 2h blood glucose \>= 11.1mmol/L). Pregnant people: the remaining fasting serum/plasma and urine samples of gestational diabetes patients (75g OGTT test FPG \>= 5.1mmol/L or 1h blood glucose \>= 10.0mmol/L or 2h blood glucose \>= 8.5mmol/L(IADPSG; ADA)). 2. Inclusion criteria of the controls were as follows: Non pregnant people: the remaining fasting serum/plasma and urine samples of normal population for glucose tolerance test (FPG 3.9-6.1mmol/L,75g OGTT test 1h blood glucose 6.7-11.1mmol/L,75g OGTT test 2h blood glucose 3.6-7.8mmol/L). Pregnant people: the remaining fasting serum/plasma and urine samples of people who do not meet the diagnostic criteria for gestational diabetes (3.9\<=75g OGTT test FPG\<5.1mmol/L,6.7 \<= 1h blood glucose\<10.0mmol/L,3.6\<=2h blood glucose\<8.5mmol/L). \- Exclusion Criteria: Common exclusion criteria for cases and control were as follows: The sample volume of serum/plasma/urine is less than 300ul; Improper storage of samples or repeated freezing and thawing; The serum /plasma has obvious hemolysis, lipemia or jaundice. \-
Where it's running
-
Zhujiang Hospital of Southern Medical University
Guangzhou, Guangdong, China Recruiting
Study contacts
- Study coordinator: Nianyi Zeng
- Email: zengny1@i.smu.edu.cn
- Phone: 13928801657
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Education on sexual dysfunction for patients with schizophrenia and diabetes
This study tests whether providing education about sexual dysfunction can help adults with schizophrenia and diabetes feel better about their sexual health while they are on antipsychotic medication.
-
Observational study on bariatric surgery outcomes
This study looks at how bariatric surgery affects weight loss and related health issues like diabetes in patients over two years after their surgery.
-
Lifestyle Metabotype Study B: Understanding Personalized Glucose Responses
This study tests how lifestyle, metabolism, and brain energy use relate to each person’s blood sugar response after meals, across people with and without prediabetes or type 2 diabetes.
-
Preventing lower limb artery disease in adults with diabetes using a risk-prediction model and HAPA-based nursing
A risk-prediction model is tested in adults with type 2 diabetes to see if a nursing plan based on the HAPA model can reduce peripheral artery disease in the legs.
-
Lifestyle Metabotype Study: How Daily Habits Shape Blood Sugar
This observational study tests whether personal lifestyle and biological factors can predict how a person’s blood sugar responds after meals.
-
Hourly stair-climbing snacks to improve blood sugar and heart health in adults with prediabetes
This study tests whether short stair-climbing bursts every hour can improve blood sugar and vascular health in adults with prediabetes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.